FindTrial
Sign In

The Corona Study of Middle Norway

The Middle Norway Corona Study - Individual and Genetic Risk Factors for COVID-19 Infection.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05638178
Acronym
CUT COVID-19
Enrollment
223
Registered
2022-12-06
Start date
2020-05-01
Completion date
2022-08-12
Last updated
2022-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SARS-CoV-2 Acute Respiratory Disease, SARS CoV 2 Infection, SARS-CoV-2 Sepsis

Brief summary

CUT COVID is a cohort study establised to collect information on patients hospitalized because or with infection by SARS-CoV-2. The cohort data includes clinical data and biological samples from multiple timepoints during hospitalization, as well as data from a followup consultation 3 months after discharge.

Interventions

OTHERNo intervention

No intervention, cohort study.

Sponsors

The Research Council of Norway
CollaboratorOTHER
Alesund Hospital
CollaboratorOTHER
Namsos Hospital
CollaboratorOTHER
Molde Hospital
CollaboratorOTHER
Helse Nord-Trøndelag HF
CollaboratorOTHER
St. Olavs Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Positive SARS CoV-2 infection

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Predictors of COVID-19 severity1 year after inclusion.Primary aim is to assess predictors of severe COVID disease in children and adults

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026